A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial

A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial

Background A growing population of patients lives with severe coronary artery disease not amenable to coronary revascularization and with refractory angina despite optimal medical therapy. Percutaneous reduction of the coronary sinus is an emerging treatment for myocardial ischemia that increases co...

Full description

Bibliographic Details
Main Authors: Jolicœur, E. Marc (Author), Banai, Shmuel (Author), Henry, Timothy D. (Author), Schwartz, Marc (Author), Doucet, Serge (Author), White, Christopher J. (Author), Edelman, Elazer R. (Contributor), Verheye, Stefan (Author)
Other Authors: Harvard University- (Contributor)
Format: Article
Language:English
Published: BioMed Central Ltd., 2013-03-21T20:15:05Z.
Subjects:
Article
Online Access:Get fulltext

Similar Items

Similar Items